UK markets open in 4 hours 57 minutes

GlaxoSmithKline plc (GSK.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
1,324.00-37.00 (-2.72%)
At close: 4:56PM GMT
Show:
Income statement
Balance sheet
Cash flow
Annual
Premium required to access quarterly data
Quarterly

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
34,998,000
33,754,000
30,821,000
30,186,000
27,889,000
Cost of revenue
12,141,000
11,863,000
10,241,000
10,342,000
9,290,000
Gross profit
22,857,000
21,891,000
20,580,000
19,844,000
18,599,000
Operating expenses
Research development
4,937,000
4,568,000
3,893,000
4,476,000
3,628,000
Selling general and administrative
11,960,000
11,402,000
9,915,000
9,672,000
9,366,000
Total operating expenses
16,535,000
15,599,000
13,516,000
13,783,000
12,573,000
Operating income or loss
6,322,000
6,292,000
7,064,000
6,061,000
6,026,000
Interest expense
882,000
885,000
771,000
736,000
717,000
Income before tax
8,138,000
6,221,000
4,800,000
3,525,000
1,939,000
Income tax expense
786,000
953,000
754,000
1,356,000
877,000
Income from continuing operations
7,352,000
5,268,000
4,046,000
2,169,000
1,062,000
Net income
6,679,000
4,645,000
3,623,000
1,532,000
912,000
Net income available to common shareholders
6,679,000
4,645,000
3,623,000
1,532,000
912,000
Basic EPS
-
0.94
0.74
0.31
0.19
Diluted EPS
-
0.93
0.73
0.31
0.19
Basic average shares
-
4,947,000
4,914,000
4,886,000
4,860,000
Diluted average shares
-
5,016,000
4,971,000
4,941,000
4,909,000
EBITDA
-
9,440,000
7,427,000
6,183,000
4,430,000